News for hackers. Stuff that matters.
Re:A cancer trial’s unexpected result: Remission in every pa... by adamredwoods on Sunday June 05, 2022 @02:02PM (#31633361)
Car-T seems promising for leukemia and lymphoma, but not as efficacious in solid tumors:

https://www.lls.org/treatment/types-treatment/immunotherapy/...

Also 2nd gen BTK inhibitors:

https://en.wikipedia.org/wiki/Acalabrutinib

https://en.wikipedia.org/wiki/Bruton%27s_tyrosine_kinase

Re:A cancer trial’s unexpected result: Remission in every pa... by elhudy on Sunday June 05, 2022 @09:42PM (#31636573)
BTK inhibitors are technically in 3rd gen (noncovalent) already if you can get in the trials (which are very promising considering they use the same mechanism).